Vitamin A Is Not a Substitute for Vaccination

When Scrolling Becomes Deadly: Confronting Viral Misinformation About Measles, MMR, and Vitamin A

The first measles death in a decade has just been reported in the United States, tragically highlighting the real and present danger of this preventable disease. As this news breaks, dangerous misinformation is already circulating, falsely claiming that measles only kills people with vitamin A deficiency. This deadly misconception is being used to scare parents away from vaccinating their children with the safe and effective MMR vaccine.

Let’s address these dangerous myths at a time when factual information is literally a matter of life and death.

KEY FACTS AT A GLANCE:

• Measles kills regardless of vitamin A status - the recent US death is in a country where vitamin A deficiency is rare

• Measles is exceptionally contagious with a 90% infection rate among susceptible individuals

• Before widespread vaccination in the US began in 1963, 3-4 million cases of measles were reported each year. It was also responsible for 48,000 hospitalizations, 1,000 cases of brain swelling (encephalitis), and 400-500 deaths each year.

• Vitamin A supplementation cannot prevent infection and has limited effectiveness once infected

• Vitamin A does not prevent measles infection and has limited proven benefits in reducing complications from measles. While it may reduce mortality in specific populations (particularly children under two), it does not reliably protect against the many serious complications that can arise from measles infection including pneumonia, encephalitis, and long-term immune suppression.

• Vitamin A is used as a treatment component for measles due to limited treatment options beyond supportive care, but it is not a preventative measure and cannot substitute for vaccination

• Even with vitamin A treatment, case fatality rates remain significant across diverse settings

• The MMR vaccine prevents 97% of measles cases with two doses

• Measles is a perfect candidate for elimination as it has no animal reservoir - it only infects humans

The US had eliminated endemic measles transmission in 2000 due to high vaccination rates, but declining vaccination coverage has allowed the virus to regain a foothold, with outbreaks now spreading rapidly among unvaccinated populations

Measles: A Serious Viral Disease Regardless of Nutritional Status

Measles is caused by a paramyxovirus that attacks epithelial tissues throughout the body, including the respiratory tract, intestines, and eyes. The infection produces a characteristic ‘bucket of paint’ rash (it's as if paint is dripping from the top of the head downward) that starts at the hairline and face and spreads downward to the rest of the body approximately 14 days after exposure, typically preceded by fever and respiratory symptoms.

Unlike many other infectious diseases, the measles virus infects only humans with no animal reservoir where the virus can persist. This characteristic makes measles an ideal candidate for complete elimination through vaccination. The United States demonstrated this possibility by eliminating endemic measles transmission in 2000 through sustained high vaccination coverage.

Measles Infectiousness:

• Each infected person can infect 12-18 susceptible individuals (compared to 2-3 for COVID-19)

• The virus remains airborne for up to two hours in enclosed spaces

• Infected individuals are highly contagious and can transmit the virus 4 days before the rash appears

Measles Complications by the Numbers:

• Pneumonia: Occurs in 1 in 20 pediatric cases and is the leading cause of measles-related deaths

• Encephalitis: Affects 1 in 1,000 cases, with 10-15% fatality rate and 25% left with permanent neurological damage

• Ear infections: Occur in ~10% of children, potentially causing permanent hearing loss

• Diarrhea and dehydration: Affects up to 8% of patients in developed countries, much higher in resource-limited settings

• Subacute sclerosing panencephalitis (SSPE): A rare but fatal degenerative disease occurring 7-10 years after infection. Based on the California Department of Public Health's findings from 1998-2015, the researchers found that:

  • SSPE is more common than previously estimated, especially in children who contract measles before age 15 months.

  • For children infected with measles before age 5, the incidence was approximately 1:1367.

  • For infants infected before 12 months of age, the incidence was even higher at about 1:609.

  • Even accounting for the potential underreporting of measles cases, conservative estimates suggest rates of 1:2700 for children under 5 and 1:1200 for infants under 12 months.

  • SSPE has a long latency period (median 9.5 years, range 2.5-34 years) between measles infection and the onset of neurological symptoms.

  • All cases with known measles infection dates were infected before the typical vaccination age of 12-15 months.

  • SSPE is universally fatal, with cognitive and motor deterioration leading to death typically within 1-3 years of symptom onset.

• "Immune amnesia": Measles wipes out immune memory cells, increasing vulnerability to other infections for 2-3 years

According to a Cochrane systematic review, vitamin A megadoses (200,000 IU on consecutive days) appear effective in reducing mortality from measles, specifically in children under two years old, with few associated adverse events. However, there is insufficient evidence to draw firm conclusions regarding its effectiveness in preventing pneumonia or other measles complications. Importantly, vitamin A provides no protection against initially contracting measles - only vaccination can prevent infection.

unbiasedscipod

A post shared by @unbiasedscipod

Case Fatality Rates (CFRs): The Deadly Reality of Measles

Recent comprehensive research has clarified the true mortality burden of measles across different settings. A systematic review analyzing data from 208 sources spanning 1990-2019 reveals the following:

2019 Community-Based Case Fatality Rates:

• Overall: 1.32% (95% UI: 1.28-1.36%)

• Children under 1 year: 3.03% (95% UI: 2.89-3.16%)

• Children 1-4 years: 1.63% (95% UI: 1.58-1.68%)

• Children 5-9 years: 0.84% (95% UI: 0.80-0.87%)

• Children 10-14 years: 0.67% (95% UI: 0.64-0.70%)

2019 Hospital-Based Case Fatality Rates:

• Overall: 5.35% (95% UI: 5.08-5.64%)

Historical and Regional Variations:

• High-income countries: Typically 0.1-0.3% in the modern era (1-3 deaths per 1,000 cases)

• Crisis settings/outbreaks in unvaccinated populations: Can reach 10-30% (100-300 deaths per 1,000 cases)

• CFRs have declined since 1990 but remain substantial, especially in young children

These statistics underscore that measles remains a significant cause of preventable death, particularly among young children, regardless of setting.

Myth #1: "Vitamin A prevents measles infection"

REALITY: Vitamin A supplementation provides zero protection against initial infection. Only the measles vaccine prevents infection.

Vitamin A supports immune function and helps maintain epithelial tissue integrity, which is attacked by the measles virus. However, no clinical trial has ever demonstrated that vitamin A can prevent a person from contracting measles when exposed to the virus.

A comprehensive Cochrane systematic review analyzing data from eight randomized controlled trials concluded there is no evidence that vitamin A prevents measles infection. The World Health Organization, Centers for Disease Control and Prevention, and the American Academy of Pediatrics all explicitly state that vitamin A cannot be a substitute for vaccination.

Statistical Evidence:

• In studies where vitamin A was administered to children with measles, 100% were already infected

• Vitamin A treatment reduced mortality but did not clear the infection or prevent its transmission

• The R₀ (basic reproduction number) of measles remains 12-18 regardless of vitamin A status

unbiasedscipod

A post shared by @unbiasedscipod

Myth #2: "Only vitamin A-deficient people die from measles"

REALITY: Measles causes significant mortality and morbidity across populations with varying vitamin A status, though deficiency increases risk substantially.

Multiple epidemiological studies have documented measles deaths in well-nourished populations with diverse vitamin A status.

US Studies on Vitamin A and Measles: Studies from the US have demonstrated that:

• Hospitalized measles patients are frequently vitamin A deficient, with levels dropping during acute infection even in otherwise well-nourished children

• In a California study, 50% of children hospitalized with measles had low vitamin A levels

• A New York City study found that vitamin A levels correlated with disease severity, but deaths occurred even in children with adequate baseline nutrition

The Limited Effect of Vitamin A on Measles Mortality

While earlier studies suggested significant benefits, more comprehensive research has raised important nuances:

New Evidence on Vitamin A Supplementation: A pooled analysis of 43 trials including 215,633 children conducted across 18 different settings between 1976 and 2010 found no effect of vitamin A supplementation on measles case fatality. This more extensive analysis challenges some earlier findings and suggests that the benefits of vitamin A may be:

• More context-dependent than previously recognized

• Potentially overestimated in some earlier, smaller studies

• Most beneficial in severely malnourished populations

• Less impactful in settings with better baseline nutrition

This doesn't mean vitamin A has no role in measles management—it remains part of WHO treatment recommendations—but it underscores that vitamin A is not a reliable substitute for vaccination and cannot guarantee survival once infection occurs.

The Samoa Measles Outbreak of 2019-2020: A Detailed Case Study

The Samoa outbreak provides a tragically clear example of why vitamin A alone is insufficient to combat measles.

Background: In 2018, Samoa temporarily suspended its measles vaccination program following an incident where two infants died after receiving incorrectly prepared vaccines (due to human error, not an issue with the vaccine itself). The resulting drop in vaccination coverage created a vulnerable population.

Outbreak Statistics:

• Vaccination coverage fell to approximately 31% of Samoan children

• The outbreak began in September 2019

• By January 2020, 5,689 measles cases were reported (nearly 3% of Samoa's population)

• 81 people died, mostly children under 5 years old

• Case fatality rate: 1.4% (15 times higher than typical high-income countries)

Vitamin A Response and Limitations:

• Vitamin A was administered in accordance with WHO guidelines as part of treatment protocols

• Despite this appropriate clinical management, deaths continued to occur

• Anti-vaccine activists, including some from abroad (including some who flew in for this special occasion from the US), promoted vitamin A as an alternative to vaccination

• Some parents delayed seeking medical care based on misinformation that vitamin A alone would be sufficient

• According to Samoan health officials, many children who died had received vitamin A but their disease had progressed too far

Resolution:

• The outbreak was ultimately controlled through a mass vaccination campaign that reached 95% coverage

• Schools were closed, public gatherings banned, and unvaccinated homes marked with red flags

• The government made it illegal to discourage vaccination during the emergency

This real-world example clearly demonstrates that while vitamin A is a component of measles treatment, it cannot replace vaccination or guarantee survival once infection occurs.

Understanding Vitamin A's Mechanism and Limitations

Vitamin A is essential for maintaining epithelial tissue integrity and immune function. During measles infection:

1. The virus causes rapid depletion of vitamin A stores through multiple mechanisms:

   • Decreased intake due to loss of appetite or anorexia

   • Impaired absorption in the intestines

   • Increased metabolic consumption

   • Increased urinary excretion

2. This depletion exacerbates measles pathology because:

   • Epithelial barriers become more vulnerable to damage

   • Immune response is compromised

   • Repair mechanisms function sub-optimally

3. Supplementation helps by:

   • Restoring depleted stores rapidly

   • Enhancing epithelial tissue regeneration

   • Supporting appropriate immune responses

WHO Treatment Recommendations: Vitamin A should be administered once daily for 2 days at these doses:

• 200,000 IU for children ≥12 months

• 100,000 IU for infants 6-11 months

• 50,000 IU for infants <6 months

Vitamin A Toxicity: The Risks of Excess Supplementation

While vitamin A is vital for health, excessive supplementation carries significant risks. Parents attempting to "protect" their children through self-administered high-dose vitamin A may inadvertently cause harm.

Acute Vitamin A Toxicity:

• Symptoms include nausea, vomiting, headache, dizziness, blurred vision, and muscle coordination problems

• In severe cases: bulging fontanelles in infants, increased intracranial pressure, and liver damage

• Documented toxic dose in children under 2 years: as low as 11,500 IU/kg

• Median toxic dose in children: approximately 47,850 IU/kg

Chronic Vitamin A Toxicity:

• Long-term excessive intake can cause bone pain, joint pain, and osteoporosis

• Skin peeling, hair loss, and liver damage may occur

• In pregnant women, doses >10,000 IU daily increase risk of birth defects

Safety of Measles Protocol Doses:

• The WHO-recommended two-dose treatment protocol has an excellent safety profile when properly administered

• These doses are intended for acute treatment, not ongoing supplementation

• Medical supervision ensures appropriate dosing by age and weight

The MMR Vaccine: Powerful Prevention with Extensive Safety Data

The measles-mumps-rubella (MMR) vaccine has been administered to billions of people worldwide with an exceptional safety record.

unbiasedscipod

A post shared by @unbiasedscipod

MMR Vaccine Efficacy:

• First dose: 93% effective at preventing measles

• Second dose: 97% effective at preventing measles

• When breakthrough infections occur, they are typically milder

Safety Profile:

• Over 50 years of safety data from billions of doses

• Most common side effects are mild: fever (1 in 6), rash (1 in 20), and temporary joint pain

• Serious allergic reactions occur in approximately 1 in 1,000,000 doses

• No credible evidence of link to autism or other developmental disorders after extensive studies of millions of children (as in ZERO)

• The vaccine's safety has been confirmed through large-scale studies across diverse populations

Global Impact:

• Measles vaccination prevented an estimated 23.2 million deaths between 2000-2018

• Before vaccination, measles caused 2.6 million deaths annually worldwide

• In countries with sustained high vaccination coverage, measles has been effectively eliminated

unbiasedscipod

A post shared by @unbiasedscipod

Comprehensive Approach to Measles Prevention and Management

While vitamin A is not a substitute for vaccination, it remains an important component of measles treatment protocols. The WHO continues to recommend vitamin A supplementation for measles patients precisely because treatment options for the virus itself are limited. Evidence suggests two doses can reduce mortality, particularly in children under two years of age. However, it's important to understand that vitamin A supplementation is a supportive treatment that may reduce complications in certain populations—not a preventative measure or cure. This reinforces why vaccination remains the primary and most effective strategy for preventing measles infection and its potentially severe consequences.

The scientific consensus on optimal measles control involves multiple complementary strategies:

1. Primary Prevention:

   • Vaccination with two doses of MMR vaccine (first dose at 12-15 months, second at 4-6 years)

   • Maintaining population immunity above 95% to prevent outbreaks

   • Special vaccination campaigns in high-risk areas

2. Post-Exposure Prevention:

   • MMR vaccine within 72 hours of exposure may prevent disease

   • Immunoglobulin within 6 days for high-risk exposed individuals who cannot receive MMR

3. Treatment of Active Infection:

   • Vitamin A supplementation per WHO guidelines

   • Supportive care with hydration and fever management

   • Antibiotics for secondary bacterial infections when necessary

   • Respiratory support when needed

4. Public Health Measures During Outbreaks:

   • Contact tracing and isolation of cases

   • Vaccination of susceptible contacts

   • Temporary school closures if necessary

   • Public education campaigns about symptoms and prevention

Conclusion: The Reality of Measles in 2025

The first measles death in a decade in the United States serves as a tragic reminder that this disease remains dangerous, even in countries with advanced healthcare systems and good nutritional status. This death was not due to vitamin A deficiency—it represents the inherent risk that measles poses to anyone who contracts it.

As measles cases continue to rise globally and in the US, we face a critical public health moment. The misinformation claiming that vitamin A can substitute for vaccination or that measles only kills the vitamin A-deficient is not merely incorrect—it is potentially deadly.

The scientific evidence unequivocally demonstrates that:

1. Measles can kill or cause permanent disability regardless of nutritional status or healthcare setting.

2. Vitamin A treatment has limited and context-dependent benefits once infection occurs, and provides zero protection against initial infection.

3. The MMR vaccine is the only proven method to prevent measles infection, with an excellent safety profile and 97% effectiveness after two doses.

4. Every unvaccinated child is at risk—not just those with vitamin A deficiency or other risk factors.

This recent death should serve as a wake-up call. Measles is not a benign childhood illness. It is a serious disease with potentially devastating consequences that modern medicine has given us the tools to prevent. Parents and communities deserve accurate information based on robust scientific evidence, not dangerous misinformation that puts children at unnecessary risk.

The consensus of global medical experts is clear: vaccination is essential, vitamin A is no substitute, and the only appropriate number of preventable measles deaths is zero.e measles deaths is zero.

You may see posts on social media claiming that measles is harmless, that vaccines are more dangerous than the disease, or that vitamin A can replace vaccination. These claims are dangerously wrong and contradict decades of medical evidence.

A reminder that death is not the only outcome of disease. Measles can lead to things like SSPE—a 100% fatal brain condition—in as many as 1 in 609 infants infected before their first birthday. This isn't fear-mongering; it's medical reality documented in peer-reviewed research.

We share this information not to frighten you, but because we care deeply about the health of your children. Vaccination isn't just about preventing a rash and fever—it's about protecting your child from permanent disability and death.

Please trust the evidence, not influencers or well-meaning but misinformed social media posts. Your family's health is too precious to gamble with misinformation.

Stay Curious (and, please, STAY SAFE),

Unbiased Science

P.S. Want to support this kind of analysis? The best way is to subscribe to our Substack and share our work. While all our articles are always completely free to read, paid subscriptions help sustain our in-depth reporting on vaccine policy and public health. Thank you for considering it!